The results from the genome-wide methylation study reported approximately 200 differentially methylated genes in DLBCL patients with the aberrant methylation of p16/CDKN2A, p21/CDKN1A, and p27/CDKN1B [124]. This evidence concerns the gene CDKN1B and diffuse large B-cell lymphoma.